Introduction Extractables & Leachables (E&L) Testing for Auto-Injectors involves the specialized chemical characterization and surveillance of substances that migrate from […]
Introduction: Establishing structural and functional similarity to an approved innovator biologic represents the cornerstone of regulatory approval for biosimilar products
Reference Product Selection and Sourcing Strategy for Biosimilar Comparability Studies Read More »
Bioanalytical CRO for Oncology Clinical Trials: Complex Matrices, PD Biomarkers, and Regulatory Expectations Within the highly specialized field of oncology
Introduction: Implementation of Nitrosamine Testing for Injectable Drug Products is a critical safety and regulatory requirement because parenteral drug products
Introduction: The immunogenicity of peptide-oligonucleotide conjugates is one of the most consequential development risks facing sponsors working with this rapidly
Introduction: PLGA Formulation Development Services encompass a highly specialized range of contract research capabilities aimed at transforming complex active pharmaceutical
Advanced Extractables & Leachables Testing for Ophthalmic Drug Products Evaluating extractables and leachables in ophthalmic formulations demands a detailed understanding
Introduction: Biosimilar development is analytically demanding. Regulatory agencies — Health Canada, the FDA, and the EMA alike — require manufacturers
Introduction to Peptide-Oligonucleotide Conjugates Specification Setting Peptide-Oligonucleotide Conjugates Specification Setting is the systematic process of establishing scientifically justified physical, chemical,
Specification Setting and Acceptance Criteria for Peptide-Oligonucleotide Conjugates Read More »
Introduction: Selecting the correct sterilization methods for PLGA drug products is one of the most consequential decisions in pharmaceutical formulation
